ANDROGRAPHOLIDE DERIVATIVES FOR USE IN THE TREATMENT OF COVID-19 DISEASE AND PULMONARY FIBROSIS ASSOCIATED WITH COVID-19

Patent number:

No items found.

Disclosed are andrographolide derivatives for use as an antiviral agent in the treatment of COVID-19 disease or pulmonary fibrosis associated with COVID-19.

Countries:

Spain

Regions:

Valencian Community

Navarre

Centers:

CSIC, UNIVERSITAT DE VALENCIA, FUNDACION PARA LA INVESTIG MEDICA APLICADA, UNIVERSIDAD PUBLICA DE NAVARRA, UNIVERSITAT POLITECNICA DE VALENCIA, FUNDACION PARA LA INVESTIGACION MEDICA APLICADA, UNIVERSIDAD DE NAVARRA

Other entities:

Sectors:

Health

Subsectors:

TRL Level:

TRL 3 – experimental proof of concept

BRL Level:

PDF Link:

Download here

Video Link:

Watch it here

Sustainable Development Goal:

Applications

Comments

Other related patents

Health

Bracelet for postural control

Countries

Spain

Health

INHIBITORS OF BUNYAVIRIDAE AND USES THEREOF

Countries

Greece

Health

Device for training the pelvic motor control while running, through electric stimulations

Countries

Spain

Get back to patents directory